Mabion S.A. (MAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.081x

Based on the latest financial reports, Mabion S.A. (MAB) has a cash flow conversion efficiency ratio of -0.081x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-5.70 Million ≈ $-1.57 Million USD) by net assets (zł70.02 Million ≈ $19.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Mabion S.A. - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Mabion S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Mabion S.A. for a breakdown of total debt and financial obligations.

Mabion S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mabion S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Creative Realities Inc NASDAQ:CREX	-0.073x
Chiu Ting Machinery Co Ltd TW:1539	0.022x
Yoo Sung Ent KO:002920	0.030x
Kim Hin Industry Bhd KLSE:5371	-0.008x
Wayi International Digital Entertainment Co TWO:3086	0.015x
Theradiag SA PA:ALTHE	1.404x
Symphony Life Bhd KLSE:1538	-0.004x
TPC CONSOLIDATED LTD. F:T7P	N/A

Annual Cash Flow Conversion Efficiency for Mabion S.A. (2009–2024)

The table below shows the annual cash flow conversion efficiency of Mabion S.A. from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Mabion S.A. market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł111.44 Million ≈ $30.67 Million	zł39.86 Million ≈ $10.97 Million	0.358x	+1905.77%
2023-12-31	zł117.78 Million ≈ $32.41 Million	zł-2.33 Million ≈ $-642.08K	-0.020x	-103.90%
2022-12-31	zł76.51 Million ≈ $21.06 Million	zł38.84 Million ≈ $10.69 Million	0.508x	+182.24%
2021-12-31	zł53.31 Million ≈ $14.67 Million	zł-32.91 Million ≈ $-9.06 Million	-0.617x	-235.56%
2020-12-31	zł-77.39 Million ≈ $-21.30 Million	zł-35.24 Million ≈ $-9.70 Million	0.455x	-70.89%
2019-12-31	zł-21.58 Million ≈ $-5.94 Million	zł-33.76 Million ≈ $-9.29 Million	1.564x	+269.28%
2018-12-31	zł42.14 Million ≈ $11.60 Million	zł-38.94 Million ≈ $-10.72 Million	-0.924x	-192.46%
2017-12-31	zł-54.16 Million ≈ $-14.91 Million	zł-54.13 Million ≈ $-14.90 Million	0.999x	+124.49%
2016-12-31	zł3.73 Million ≈ $1.03 Million	zł-15.22 Million ≈ $-4.19 Million	-4.082x	-1433.70%
2015-12-31	zł127.64 Million ≈ $35.13 Million	zł-33.97 Million ≈ $-9.35 Million	-0.266x	-988.98%
2014-12-31	zł997.84 Million ≈ $274.62 Million	zł-24.39 Million ≈ $-6.71 Million	-0.024x	+53.89%
2013-12-31	zł520.55 Million ≈ $143.26 Million	zł-27.59 Million ≈ $-7.59 Million	-0.053x	-615.46%
2012-12-31	zł1.82 Billion ≈ $502.09 Million	zł-13.51 Million ≈ $-3.72 Million	-0.007x	+98.71%
2011-12-31	zł20.37 Million ≈ $5.60 Million	zł-11.74 Million ≈ $-3.23 Million	-0.576x	-794.40%
2010-12-31	zł21.72 Million ≈ $5.98 Million	zł-1.40 Million ≈ $-385.19K	-0.064x	-101.62%
2009-12-31	zł-74.80K ≈ $-20.59K	zł-298.41K ≈ $-82.13K	3.990x	--

About Mabion S.A.

WAR:MAB Poland Biotechnology

Market Cap

$33.23 Million

zł120.73 Million PLN

Market Cap Rank

#23379 Global

#216 in Poland

Share Price

zł7.47

Change (1 day)

+3.75%

52-Week Range

zł6.82 - zł10.64

All Time High

zł134.60